human-immunodeficiency-virus-hiv

Documents about human-immunodeficiency-virus-hiv

• HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections#1320951ClinicalTrials.gov
• HCV/HIV Coinfection: Antiviral Therapy and Fibrosis#915202ClinicalTrials.gov
• The Human Immunodeficiency Virus and Osteopathic Manipulation Evaluation Study#1397064ClinicalTrials.gov
• MK-8510 Monotherapy for the Treatment of Anti-retroviral naïve Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants (MK-8510-002)#1245722ClinicalTrials.gov
• Human Immunodeficiency Virus (HIV)#339164Southampton
• Human Immunodeficiency Virus (HIV) Postexposure Prophylaxis (PEP) With Darunavir/Ritonavir (DRV/r)#1338549ClinicalTrials.gov
• Fostemsavir Compassionate Use Named Patient Program for the Treatment of Human Immunodeficiency Virus 1 (HIV-1)#1382908ClinicalTrials.gov
• ICVAX as a HIV Therapeutic DNA Vaccine#143663ClinicalTrials.gov
• A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)#838597ClinicalTrials.gov
• Active Hexose Correlated Compound in Tuberculosis-HIV (Human Immunodeficiency Virus) Infection#1151408ClinicalTrials.gov
• An Extension Protocol for Subjects Who Successfully Completed PRO140_CD02 or PRO140_CD02_Open Label Study#842673ClinicalTrials.gov
• Dose, Safety, Tolerability, and Immunogenicity of an HIV-1 Vaccine, VRC-HIVRGP096-00-VP, With Alum in Healthy Adults#871319ClinicalTrials.gov
• A Study of MGD020 Alone or Combined With MGD014 in Persons With HIV-1 on Antiretroviral Therapy#1244705ClinicalTrials.gov
• PRO 140 for Human Immunodeficiency Virus#1008969ClinicalTrials.gov
• Feasibility of a Stigma Reduction Intervention for Human Immunodeficiency Virus (HIV)-Infected Women#848427ClinicalTrials.gov
• Incidence of Human Immunodeficiency Virus-1 (HIV-1) Infection in HIV-1 Uninfected High Risk Men Who Have Sex With Men#826954ClinicalTrials.gov
• The Safety and Immunogenicity of the DNA-GTU Vaccine Administered to HIV-infected Patients on ART vs Placebo#850096ClinicalTrials.gov
• HIV Therapeutic DNA Vaccine (ICVAX) Phase I Clinical Trial in Hong Kong#28427ClinicalTrials.gov
• PRO 140 for Human Immunodeficiency Virus Infection#890829ClinicalTrials.gov
• Identifying Challenges to Healthy Aging in Persons With Human Immunodeficiency Virus (HIV) Age 50 and Older#891936ClinicalTrials.gov
• Safety and Efficacy Study of Vaccine Schedule With Ad26.Mos.HIV and MVA-Mosaic in Human Immunodeficiency Virus (HIV)-Infected Adults#1007759ClinicalTrials.gov
• Radiopaque Matrix MK-8591 Implant in Participants at Low-Risk for Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591-043)#1125868ClinicalTrials.gov
• COMO: Cognition Study With HIV+ Patients (CTNPT 015)#1451422ClinicalTrials.gov
• Prospective Epidemiological Study Of The Prevalence Of HLAB*5701 In HIV-1 Infected Patients#915918ClinicalTrials.gov
• Advancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study#1349246ClinicalTrials.gov
• HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR by Antiviral Therapy#831606ClinicalTrials.gov
• Observational Study of HIV-associated Neurocognitive Disorder#832410ClinicalTrials.gov
• Regional Differences in Human Immunodeficiency Virus (HIV) Testing#858222ClinicalTrials.gov
• Reality Check: An HIV Risk Reduction Serial Drama#873507ClinicalTrials.gov
• A Study to Assess the Acceptability of the Darunavir/Cobicistat (DRV/COBI) Fixed-dose Combination (FDC) Tablet in Human Immunodeficiency Virus (HIV)-1 Infected Children#887036ClinicalTrials.gov
• The Effects of Chiropractic Care on Inflammation and Quality of Life in People Living With HIV#1498951ClinicalTrials.gov
• Pre-Exposure Prophylaxis Using TMC278LA#806664ClinicalTrials.gov
• A Study to Evaluate the Performance, Usability, and Result Interpretation of INSTI® HIV Self-Test#1418805ClinicalTrials.gov
• Inflammation and Depression in People With HIV#1445119ClinicalTrials.gov
• Alcohol Monitor Validation#1008746ClinicalTrials.gov
• Inflammasome Activation Via Circulating Metabolites#1184751ClinicalTrials.gov
• Omacor and Cardiovascular Risk Factors in HIV Patients on HAART Treatment#1369969ClinicalTrials.gov
• Safety And Efficacy Of Rescriptor In Patients For Human Immunodeficiency Virus (HIV) Patients#1214599ClinicalTrials.gov
• Safety, Reactogenicity and Immunogenicity of HB-502 and HB-501 Versus Placebo in People With HIV on Suppressive ART#1184464ClinicalTrials.gov
• Phase 4 Study of Dolutegravir (DTG) in Russian Federation#1114301ClinicalTrials.gov
• A Study to Assess the Safety and Effectiveness of Darunavir for Treating Human Immunodeficiency Virus-Type I (HIV-1) Infection in Filipino Patients#1453531ClinicalTrials.gov
• Evaluation of a Human Immunodeficiency Virus (HIV) Blood Screening Assay#882057ClinicalTrials.gov
• Regular HIV Testing Among At-Risk Latino Men#1438009ClinicalTrials.gov
• Study to Evaluate the Safety Tolerability and Acceptability of Long Acting Injections of the Human Immunodeficiency Virus (HIV) Integrase Inhibitor, GSK1265744, in HIV Uninfected Men (ECLAIR)#802473ClinicalTrials.gov
• A Study of Islatravir (ISL) and Ulonivirine (ULO) Once Weekly (QW) in Virologically Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8591B-060)#830149ClinicalTrials.gov
• Video Information Provider for HIV-Associated Non-AIDS (VIP-HANA) Symptoms#1104295ClinicalTrials.gov
• Long-term Immunogenicity of the HIV gp120-NefTat/AS01B Vaccine (GSK SB732461)#226329ClinicalTrials.gov
• Determine the Prevalence and Severity of Asthma in HIV (Human Immunodeficiency Virus) Infected Patients#826842ClinicalTrials.gov
• Tuberculosis and Human Immunodeficiency Virus (HIV) Immune Reconstitution Syndrome Trial (THIRST)#1072949ClinicalTrials.gov
• GSK1349572 Relative Bioavailability Study#874734ClinicalTrials.gov